WebAug 2, 2024 · Chromogranin A can be used to aid detection and surveillance of neuroendocrine tumors. It can be elevated with: pheochromocytoma medullary thyroid carcinoma enterochromaffin and pancreatic islet cell tumors autoimmune chronic atrophic gastritis gastrinoma multiple endocrine neoplasia syndrome type 1 WebFeb 12, 2024 · Chromogranin A and its derivatives are biomarkers for several conditions. 60-80% of neuroendocrine tumor patients demonstrated elevated chromogranin A. A connection with Alzheimer’s disease has recently been reported. Rheumatoid arthritis and lupus patients may have elevated CgA as a result of increased tumor necrosis factor.
Chromogranin A as Serum Marker for Neuroendocrine Neoplasia: …
WebThe follow-up was complete and ranged from 12 to 86 months (mean: 49 months). Results: Plasma CgA levels were significantly or moderately elevated in all patients with liver metastases at diagnosis (64.3%). The levels also reflected tumour progression or response to treatment during the follow-up period. WebChromogranin A (CgA) is a 49-kD protein that is contained in the neurosecretory vesicles of NET cells and is …. Clinical presentation and diagnosis of pheochromocytoma. …catecholamines and metabolites may be invalid if the patient has advanced kidney disease . Serum chromogranin A levels have poor diagnostic specificity in these patients . sharetown rep login
Chromogranin A Test - Testing.com
WebOct 17, 2015 · Chromogranin A (CgA) A blood tumor marker used for detection of certain cancers. Chromogranin A is considered the best general neuroendocrine serum or … WebSep 24, 2024 · Chromogranin A is a secretory protein, composed of 439 amino acids, found in the large dense-core vesicles of the neuroendocrine cells. It belongs to the family of granins that includes... WebApr 1, 2024 · Chromogranin A is a secreted protein that may be elevated in patients with neuroendocrine tumors; elevated levels have been associated with poorer prognosis. Currently, Chromogranin A (CgA) is a well-established marker for diagnosis and follow up of patients with gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN). sharetown reddit